Completed NA INTERVENTIONAL 1-arm NCT00625313

Clinical Study of a UV-Absorbing Acrylic Posterior Chamber Intraocular Lens (HMY)

A Prospective, Multi-center, Single-phase, Non-randomized, Open-label Study to Assess the Safety and Efficacy of the HMY Model YA-60BB Intraocular Lens (IOL) for the Correction of Aphakia Following Phacoemulsification Cataract Extraction

Sponsor: Hoya Surgical Optics, Inc.

Conditions Aphakia

Interventions HMY Model YA-60BB IOL

Updated 6 times since 2017 Last updated: Aug 17, 2015 Started: Mar 31, 2004 Primary completion: Dec 31, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00625313, this NA trial focuses on Aphakia and remains completed. Sponsored by Hoya Surgical Optics, Inc., it has been updated 6 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hoya Surgical Optics, Inc.

Data source: Hoya Surgical Optics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chino Hills, United States